INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO PARA DETERMINAR ANTICUERPOS IGA, IGG E IGM ESPECÍFICOS FRENTE A CHLAMYDOPHILA PNEUMONIAE
Mexico·Clase I·III. Agentes de diagnóstico·KABLA COMERCIAL,
S.A. DE C.V.·Registered December 14, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- CHLAMYDOPHILA PNEUMONIAE VIRCLIA® IGA/IGG/IGM MONOTEST
- Trade Name (English)
- CHLAMYDOPHILA PNEUMONIAE VIRCLIA® IGA/IGG/IGM MONOTEST
- Analysis ID
- 1574R2022 SSA
- Registration Date
- December 14, 2022
- Name (Spanish)
- KABLA COMERCIAL, S.A. DE C.V.
- Name (English)
- KABLA COMERCIAL, S.A. DE C.V.
Access comprehensive regulatory information for INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO PARA DETERMINAR ANTICUERPOS IGA, IGG E IGM ESPECÍFICOS FRENTE A CHLAMYDOPHILA PNEUMONIAE (INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO PARA DETERMINAR ANTICUERPOS IGA, IGG E IGM ESPECÍFICOS FRENTE A CHLAMYDOPHILA PNEUMONIAE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1574R2022 SSA and manufactured by KABLA COMERCIAL, S.A. DE C.V.. The device was registered on December 14, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.